1. Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccination. Issue 1 (January 2023) Authors: Nakagama, Yu; Chi, Sung-Gi; Minami, Yosuke; Watanabe, Reiko; Yamagishi, Michiteru; Atsuko, Uno; Kido, Yasutoshi Journal: Journal of infection and chemotherapy Issue: Volume 29:Issue 1(2023) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗